期刊文献+

拜糖平干预治疗IGT转归临床观察 被引量:5

An evalualion on efficacy of acarbose interfering trentment on IGT
在线阅读 下载PDF
导出
摘要 目的:观察拜糖平对糖耐量低减(IGT)干预治疗的转归,寻求糖尿病(DM)二级预防的可能性。方法:选择IGT61例,随机分成两组,拜糖平组31例,对照组30例,以拜糖平50mgTid,干预治疗一年,观察IGT转归,结果与对照组相比,拜糖平能降低IGT向DM的转化率,并能增加IGT向正常糖耐量(NGT)的转化率。 Objective:Observe the change of Acarbose to IGT( inpaired glucose tolerance) and explore the possibility of DM ( diabetic mullitus) second- class prevention. Methods:Choose sixty- one example IGT and divide them into two groups stochastically,choose thirty- one examples as Acarbose groups and thirty exam ples as contrast groups.Interfere and treat IGT for one year with Acarbose5 0 m g Tid,observing the changes of IGT and com paring the contrast groups. Then you can find outthat Acarbose can reduce the changing rate from IGT to DM,and also raise the changing rate from IGT to NGT( normal glucose toterance) .
出处 《山西临床医药》 2000年第2期116-117,共2页 Shanxi Clinical Medicine
关键词 糖耐量低减 拜糖平 糖尿病 治疗 IGT acarbose diabetus
  • 相关文献

参考文献5

二级参考文献3

  • 1潘孝仁,Diabretes Care,1993年,16卷,150页
  • 2胡英华,中华内科杂志,1993年,32卷,173页
  • 3团体著者,中华内科杂志,1981年,20卷,678页

共引文献336

同被引文献54

  • 1丰德恒,沙松林.拜糖平干预治疗糖耐量减低的疗效观察[J].现代医药卫生,1998,14(2):68-69. 被引量:1
  • 2方懿珊,李统艺,陈师毅.药物与非药物干预对糖耐量减低者结局的影响:5年随访[J].中国临床康复,2004,8(30):6562-6563. 被引量:6
  • 3梁强,邬磊,刘鹏鹰.糖耐量减退患者的药物干预效果[J].实用医技杂志,2004,11(10A):1947-1949. 被引量:2
  • 4潘孝仁,李光伟,胡英华,王继兴,杨文英,安作新,刘娟,曹辉碧,胡泽溪,庞成言,张辉,郑辉,王金平,姜希贵,姜亚云.饮食和运动干预治疗对糖尿病发病率的影响──530例糖耐量低减人群六年前瞻性观察[J].中华内科杂志,1995,34(2):108-112. 被引量:243
  • 5Uusitupa M, Louheranta A, Lindstrom J, et al. The FinnishDiabetes Prevention Study. Br J Nutr ,2000,83(Suppl 1): 137
  • 6Takerua Y, Kikuchi S, Inaba Y, et al. The protective effect of good physical fitness when young on impaired glucose tolerance when old. Prev Med, 1999,28 (1): 14.
  • 7Sato Y, Sato J, Tokudome S. Management of impaired glucose tolerance: physical training therapy. Nippon Rinsho, 1996,54 (10) :2745
  • 8Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care, 1996,19(2): 112
  • 9Vuksan V, Sievenpiper JL, Owen R, et al. Beneficial effects of viscous dietary fiber from Konjac - mannan in subjects with the insulin resistance syndrome:results of a controlled metabolic trial. Diabetes Care, 2000,23(1) :9
  • 10Chiasson JL,Gomis R,Hanefeld M,et al. The STOP - NIDDM Trial: an international study on the efficacy of an alpha - glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non- Insulin- Dependent Diabetes Mellitus. Diabetes Care, 1998,21(10): 1720

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部